Clinimetría y desarrollo tecnológico en ejercicio terapéutico
CLIDET
University of Leicester
Leicester, Reino UnidoPublicaciones en colaboración con investigadores/as de University of Leicester (2)
2017
-
Impact of baseline glycated haemoglobin, diabetes duration and body mass index on clinical outcomes in the LixiLan-O trial testing a titratable fixed-ratio combination of insulin glargine/lixisenatide (iGlarLixi) vs insulin glargine and lixisenatide monocomponents
Diabetes, Obesity and Metabolism, Vol. 19, Núm. 12, pp. 1798-1804
2015
-
A decision support tool for appropriate glucose-lowering therapy in patients with type 2 diabetes
Diabetes Technology and Therapeutics, Vol. 17, Núm. 3, pp. 194-202